• Download the PDF version of highlights of our conference coverage (2.5MB).

Cardiovascular Complications of HIV/HAART

• A Review of the Cardiovascular Complications of HIV/HAART
  Coverage by Corklin R. Steinhart, M.D., Ph.D.
• HIV-Infected Patients Have Multiple Risk Factors for Cardiovascular Disease (Poster 712)
  Coverage by Pablo Tebas, M.D.

• Color Doppler Ultrasonographic Comparison of PI vs. NNRTI Regimens (Poster 735)
  Coverage by Pablo Tebas, M.D.

Metabolic Complications of HIV/HAART

• An Overview of the Metabolic Complications of HIV/HAART
  Coverage by Pablo Tebas, M.D.
• Osteopenia and Osteoporosis in HIV-Infected Adults and Children (Symposium 47)
  Coverage by Pablo Tebas, M.D.

• Unboosted Atazanavir Better on Insulin Sensitivity Compared to Lopinavir/Ritonavir (Poster 702)
  Coverage by Calvin J. Cohen, M.D., M.S.

• No Lipodystrophy Yet Seen With Regimens Including Enfuvirtide (Poster 715)
  Coverage by Calvin J. Cohen, M.D., M.S.

• Predicting Lipoatrophy After Treatment Initiation (Poster 722)
  Coverage by Pablo Tebas, M.D.

Other Complications of HIV/HAART

• An Update on the Diagnosis and Management of HIV-Associated Peripheral Neuropathy (Oral 34)
  Coverage by Keith Henry, M.D.

• Deaths Down for People With AIDS; Causes Shift From AIDS- to Age-Related Diseases (Poster 872)
  Coverage by Corklin R. Steinhart, M.D., Ph.D.

• Quality of Life Impact of Non-AIDS-Related Serious Adverse Events Versus AIDS-Related Events (Poster 874)
  Coverage by Corklin R. Steinhart, M.D., Ph.D.

Epidemiology

• HIV Spreads to General Population in Former Soviet Union
  Coverage by Bonnie Goldman and Miriam Stone

HIV Drugs in Development

• New Antiretroviral Drugs in Development
  Coverage by David Wohl, M.D.
• GW873140, a Promising CCR5 Inhibitor Candidate (Oral 139)
  Coverage by Benjamin Young, M.D., Ph.D.

• A Look at Antiretroviral Agents in Development -- An Attachment Inhibitor and Two CCR5 Receptor Antagonists (Oral 139, 141)
  Coverage by Edwin DeJesus, M.D.

HIV Infection and Pregnancy

• Nevirapine Well Tolerated in HIV-Infected Pregnant Women (Posters 923, 939)
  Coverage by Andrew T. Pavia, M.D.

HIV Treatment

• HIV Superinfection 5% in Newly Infected Gay Men (Oral 21)
  Coverage by Keith Henry, M.D.

• Little Benefit Seen for Treatment During Acute Infection (Oral 24)
  Coverage by Keith Henry, M.D.

• Drug Monitoring, NRTI Activity Help Predict Lopinavir/Ritonavir Response in Experienced Patients (Oral 134)
  Coverage by Paul E. Sax, M.D.

• Boosted Atazanavir Similar to Boosted Lopinavir in Treatment-Experienced Patients (Poster 547)
  Coverage by Calvin J. Cohen, M.D., M.S.

• Dual-PI Regimen Preferred Over Single-PI Regimen After Initial PI Failure (Poster 548)
  Coverage by Edwin DeJesus, M.D.

• Substudy of 2NN Shows Nevirapine and Efavirenz to Be Equal in Potency (Poster 550)
  Coverage by Gerald Pierone, Jr., M.D.

• Virologic Failure Analyzed in a Trial of Once-Daily Versus Twice-Daily Abacavir With 3TC and Efavirenz (Poster 551)
  Coverage by Andrew T. Pavia, M.D.

• Gender, Youth, Race/Ethnicity, Treatment Interruption Tied to Risk for Virologic Failure (Poster 553)
  Coverage by Edwin DeJesus, M.D.

• Once-Daily Lopinavir/Ritonavir as Effective as Twice-Daily, but Greater Side Effects Are Concern (Poster 570)
  Coverage by Paul E. Sax, M.D.

• Triple-PI Regimens for Rescue Treatment (Posters 611, 612)
  Coverage by Benjamin Young, M.D., Ph.D.

• Little Difference Between Resistance Testing Methods in Treatment-Experienced Patients (Poster 675)
  Coverage by Mark Holodniy, M.D., F.A.C.P., C.I.C.

• Enfuvirtide Safe and Effective for Adolescents (Poster 929)
  Coverage by Calvin J. Cohen, M.D., M.S.

HIV/Hepatitis C Coinfection

• Hepatitis C May Negatively Impact Neurocognitive Function (Oral 26)
  Coverage by Gerald Pierone, Jr., M.D.

• Nelfinavir, Lopinavir/Ritonavir Appear Safe for Hepatitis C Patients (Poster 811)
  Coverage by Paul E. Sax, M.D.

• Liver Transplants Safe, Successful in Otherwise Healthy HIV Patients (Posters 826-828)
  Coverage by Myles Helfand

Prevention/HIV Testing

• Unique HIV Testing Program in North Carolina (Oral 20)
  Coverage by Keith Henry, M.D.

• Unique, Endangered Program Discovers HIV Outbreak in "Real Time" (Orals 83, 84, 85LB, Poster 846)
  Coverage by Bonnie Goldman and Myles Helfand

Structured Treatment Interruption

• Structured Treatment Interruption -- Part I: Overview
  Coverage by Gerald Pierone Jr., M.D.
• Structured Treatment Interruption -- Part II: Case Studies
  Coverage by Gerald Pierone Jr., M.D.
• Single-Drug Interruption May Be Useful in Identifying Still-Active Drugs in Heavily Treated Patients (Poster 623)
  Coverage by Gerald Pierone, Jr., M.D.